Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Depreciation & Amortization (CF) (2016 - 2025)

HealthLynked (HLYK) has disclosed Depreciation & Amortization (CF) for 10 consecutive years, with $20155.0 as the latest value for Q3 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 75.64% to $20155.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $103853.0, a 69.7% decrease, with the full-year FY2024 number at $282950.0, down 19.62% from a year prior.
  • Depreciation & Amortization (CF) was $20155.0 for Q3 2025 at HealthLynked, down from $27238.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $211658.0 in Q1 2021 to a low of $20155.0 in Q3 2025.
  • A 5-year average of $124609.0 and a median of $88265.0 in 2023 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): surged 753.94% in 2021, then plummeted 75.64% in 2025.
  • HealthLynked's Depreciation & Amortization (CF) stood at $204258.0 in 2021, then increased by 1.43% to $207175.0 in 2022, then tumbled by 57.4% to $88265.0 in 2023, then tumbled by 67.78% to $28436.0 in 2024, then fell by 29.12% to $20155.0 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Depreciation & Amortization (CF) are $20155.0 (Q3 2025), $27238.0 (Q2 2025), and $28024.0 (Q1 2025).